Latine individuals in the US face higher morbidity and mortality in skin cancer outcomes despite lower lifetime risk.
Despite making up the second largest ethnic group in the US, Latine and Hispanic individuals face alarming disparities in skin cancer outcomes, according to a review published in Cutis in collaboration with the Skin of Color Society.1
The review showed that while their lifetime risk of developing skin cancer is lower than that of non-Hispanic White individuals, Latine patients are more likely to receive a diagnosis at a more advanced stage and experience higher rates of morbidity and mortality. According to the authors, factors contributing to these ethnic disparities include delays in diagnosis, limited awareness about skin cancer risks, and inequities in access to care.
The unique clinical features of skin cancer in Latine patients often complicate early detection. For instance, melanoma in Latine individuals commonly manifests on the torso, lower extremities, and less visible areas like the soles of the feet or under nails, making it easier to overlook. Other research looking at melanoma knowledge among patients of color has shown that many are unaware of the risk for melanoma on acral sites like palms and soles, highlighting the need for more inclusive education.2
“Improving cultural misconceptions regarding skin conditions, especially skin cancer, is another important consideration in the Latine/Hispanic community,” the authors added.1,3 “Many Latine/Hispanic individuals wrongly believe they cannot develop skin cancer due to their darker skin tones and lack of family history.”
Insurance coverage disparities are another major contributor to poor skin cancer outcomes for Latine and Hispanic patients.1 Nearly 1 in 5 Latine individuals in the US lack health insurance, compared with only 8% of non-Hispanic White individuals, limiting their access to preventive screenings and timely treatments. Latine employees are also less likely to receive employer-sponsored health care coverage than their White counterparts (27% vs 53%). Even among those with insurance, high out-of-pocket costs and fear of financial strain discourage some from seeking care.
“Other factors that may impact skin cancer outcomes in this population include (but are not limited to) lack of or inadequate health insurance, medical mistrust, linguistic barriers and/or individual/cultural perspectives, along with limited research,” the authors added. “Recognizing and addressing these (albeit complex) barriers that contribute to the inequitable access to health care in this population remains a critical step toward improving skin cancer outcomes.”
Medical mistrust among Latine/Hispanic patients is often rooted in experiences of discrimination within health care settings and significantly impacts treatment adherence and health outcomes. A survey included in the review showed strong links between mistrust and perceived discrimination based on race, language, income, and insurance status. Even after adjusting for race and language, income-based discrimination persisted, and patients relying on public insurance like Medicare reported higher levels of mistrust compared with those holding private insurance.
“Together, these findings support the notion that individuals who have low socioeconomic status and lack insurance coverage—disproportionately historically marginalized populations—are more likely to perceive discrimination in health care settings, have greater medical mistrust, and experience poorer health outcomes.”
With the Latine community projected to grow to over 25% of the US population by 2060, addressing these disparities is a public health imperative.
References
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More